Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ublituximab (LFB-R603; TG-1101; TGTX-1101), a next-generation type 1 chimeric monoclonal antibody, specifically targets a unique epitope on the CD20 antigen and demonstrates anticancer effects [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder |
Description | Ublituximab (LFB-R603; TG-1101; TGTX-1101), a next-generation type 1 chimeric monoclonal antibody, specifically targets a unique epitope on the CD20 antigen and demonstrates anticancer effects [1]. |
Cas No. | 1174014-05-1 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.